Our team has supported exceptional early-stage ventures
![header thumb print](https://pven.wpengine.com/wp-content/uploads/2020/10/headder_thumb_print_mobile_v1-2.png)
Our 35-year history has demonstrated success in selecting
partners and supporting commercial goals.
![gray_devider_bar_top_v1](https://pven.wpengine.com/wp-content/uploads/2020/10/gray_devider_bar_top_v1-2.png)
![Mobile](https://pven.wpengine.com/wp-content/uploads/2020/10/gray_devider_bar_top_mobile_v1.png)
Key Activities and Outcomes
![Enliven_Logo](https://purohitventures.com/wp-content/uploads/2023/05/Enliven_Logo.png)
Clinical stage oncology therapeutics
• Corporate identity
• Investor targeting strategy
• PR strategy and support
• Clinical conference support
$165M
Private
Placement
![True North Logo](https://purohitventures.com/wp-content/uploads/2020/10/true_north_logo-1.png)
Pre-commercial (rare disease)
hematology biotech
• Patient journey mapping
• Clinical planning support
• Early-stage product positioning strategy
• Pricing and forecast modeling
$825M
Acquisition by
Bioverativ
![CareDX](https://purohitventures.com/wp-content/uploads/2020/10/CareDx_Logo_mobile.png)
Commercial-stage transplant diagnostics
• Portfolio alignment strategy
• Corporate and product identity
• Investor strategy
$40M
IPO
![Monogram Logo](https://purohitventures.com/wp-content/uploads/2020/10/monogram_logo.png)
Pre-commercial diagnostics firm
• Corporate identity
• Target selection support
• Launch strategy
• Product brand development